Current Research: Pediatric Hematology-Oncology


Back to Pediatric Hematology-Oncology Research


AREN03B2 -- Renal Tumors Classification, Biology, and Banking Study

The purpose of this research study is to classify patients with renal tumors by histological categorization, surgico-pathological stage, presence of metastases, age at diagnosis, tumor weight, and loss of heterozygosity for chromosomes 1p and 16q, and to define eligibility for a series of therapeutic studies. Secondary objectives for the trial include:

  • Monitor outcome for those patients who are not eligible for a subsequent therapeutic study.
  • Describe whether the pulmonary tumor burden correlates with outcome in patients with stage IV disease.
  • Correlate the method of conception (natural vs assisted reproductive technology) with the development of Wilms' tumor.

Eligibility

Patients may be eligible for this trial if:

  • Patients must be < 30 years old at the time of diagnosis
  • Patients with tumors of the following histologic type are eligible for this study:
    • Nephroblastic tumors
      • Nephroblastoma (Wilms' tumor) (favorable histology, anaplasia [diffuse, focal])
      • Nephrogenic rests and nephroblastomatosis
      • Cystic nephroma and cystic partially differentiated nephroblastoma
      • Metanephric tumors (metanephric adenoma, metanephric adenofibroma, metanephric stromal tumor)
    • Mesoblastic nephroma (cellular, classic, mixed)
    • Clear cell sarcoma
    • Rhabdoid tumor (any malignant rhabdoid tumor occurring outside the CNS)
    • Renal epithelioid tumors of childhood (papillary renal cell carcinoma, medullary renal cell carcinoma, renal tumors associated with Xp11.2 translocations, oncocytic renal neoplasms after neuroblastoma)
    • Angiolipoma
    • Ossifying renal tumor of infancy

Trial Sponsor

  • Children’s Oncology Group (COG); National Cancer Institute (NCI)

Project Begin Date

  • Mar 2007

Tentative Project End Date

  • Ongoing

Back to Pediatric Hematology-Oncology Research

Revised March 30, 2009.   Please send comments, suggestions or questions about this page to Goldei Posey, gposey@mcg.edu .